Kazakhstan, India to launch pharmaceutical plant in Almaty region
Photo: KAZAKH INVEST
A Memorandum of Understanding (MoU) has been signed between India’s MSN Laboratories Pvt. Ltd., Kazakhstan’s Medservice Plus LLP, and the national investment promotion company KAZAKH INVEST, marking the launch of a joint pharmaceutical project in the Almaty region.
Access to paid information is limited
If You already have a account, please log in
Subscription to paid content
Gain access to all that Trend has to offer, as well as to premium, licensed content via subscription or direct purchase through a credit card.
